Intensive research in the field is now aimed at better understanding the molecular mechanisms that leptin triggers in tumor cells and discovering new molecular targets for therapy in patients with breast cancer and obesity. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.